For nearly two decades, a pair of Israeli chemists pursued the inner architecture of one of humanity's oldest killers, driven by personal memory and scientific curiosity in equal measure. At the Weizmann Institute of Science, Leslie Leiserowitz and Michael Elbaum led an international team of 17 researchers to produce the first complete atomic map of hemozoin — the dark crystals a malaria parasite builds to neutralize its own toxic waste and survive inside human blood. The discovery matters because most antimalarial drugs work by disrupting this very crystallization process, and understanding i
Israeli researchers decode malaria parasite's crystal structure, paving way for new drugs
Cobertura Relacionada
El Ejército yemení anunció la muerte de dos oficiales en combates recientes contra fuerzas hutíes, marcando una intensif…
El País · Aug 24 El matemático iraní Shayan Oveis Gharan gana la Medalla Abacus 2026 en EE UUShayan Oveis Gharan, nacido en Irán, recibe la Medalla Abacus 2026 por sus contribuciones a algoritmos. Reflexiona sobre…
El Tiempo · Aug 24 Agencias internacionales alertan sobre planes de desestabilización en seis regiones de ColombiaInforme de inteligencia de 18 páginas de agencias estadounidenses e israelíes revela planes coordinados para desestabili…
dw.com · Aug 24 Siria confirma diálogos de alto nivel con Israel para reducir tensionesSiria confirmó conversaciones de alto nivel con Israel en Jordania mediadas por EE.UU., buscando reducir tensiones tras …
Sesgo y Encuadre
No hay datos de análisis detallado para esta lente. Intenta volver a ejecutar las lentes desde el panel de administración.
Impacto Geopolítico
Israeli researchers' malaria parasite breakthrough has minimal geopolitical impact; primarily a scientific advancement with global health benefits rather than strategic implications.
Strengthens Israel's soft power through scientific leadership in medical research; enhances international scientific collaboration; positions Weizmann Institute as key player in global health innovation without altering state-level power balances.
Similar to Jonas Salk's polio vaccine (1950s)—scientific breakthroughs transcend geopolitics and generate international goodwill, though this malaria research is more incremental than paradigm-shifting.
Lente Económico
Israeli researchers decoded malaria parasite crystal structure, enabling development of more effective antimalarial drugs against drug-resistant strains with significant implications for pharmaceutical R&D and global health markets.
Consumers in malaria-endemic regions (primarily Africa, Asia, Latin America) could benefit from more effective, potentially cheaper antimalarial treatments with fewer side effects. Reduced disease burden could lower healthcare costs and improve productivity in affected populations.
Potential acceleration of drug approval pathways for antimalarial compounds; increased public health funding for malaria research and treatment programs; possible patent and intellectual property considerations; WHO may update treatment guidelines; increased investment in tropical disease research infrastructure.